What does Bayer AG do?

What does Bayer AG do?

Bayer produces various fungicides, herbicides, insecticides, and some crop varieties. Fungicides are primarily marketed for cereal crops, fresh produce, fungal with bacteria-based pesticides, and control of mildew and rust diseases.

What does Bayer AG mean?

AG is an abbreviation of Aktiengesellschaft, which is a German term for a public limited company. This type of company shares are offered to the general public and traded on a public stock exchange. Shareholders’ liability is limited to their investment.

Is Bayer a biotech company?

Bayer Corporation Biotechnology Plant, Berkeley, California, US – Pharmaceutical Technology.

What brands does Bayer make?

Find our most known Pharmaceuticals brands in our product list.

  • These products include globally known brands such as Aleve™, Alka Seltzer™, Aspirin™, Bepanthen™/Bepanthol™, Berocca™, Canesten™, Claritin™, Elevit™, Iberogast™, MiraLAX™, One-A-Day™, Rennie™ and Redoxon™.
  • Is Bayer a German company?

    Bayer, in full Bayer AG, German chemical and pharmaceutical company founded in 1863 by Friedrich Bayer (1825–80), who was a chemical salesman, and Johann Friedrich Weskott (1821–76), who owned a dye company. and manufactured dyestuffs; in 1881 it was incorporated as Farbenfabriken vormals Friedr.

    Is Bayer an anti-inflammatory?

    Bayer Aspirin (aspirin) is a nonsteroidal anti-inflammatory drug (NSAID) prescribed for treating fever, pain, inflammation in the body, prevention of blood clots, and reduction of the risk of strokes and heart attacks. Bayer Aspirin is available as a generic drug.

    Who controls Bayer AG?

    Bayer employs more than 115,000 people worldwide. More than 13,000 employees work at its 50-plus U.S. facilities. German businessman Werner Baumann is Bayer’s CEO.

    Is Bayer stock undervalued?

    Currently, 24 S&P global analysts value Bayer at a target of €61/share, which gives us a 21% undervaluation. This is already lower than the price target 1 year ago, and in this company, we have clear times when analysts have been either spot-on or have even undervalued and under-targeted this company.